Literature DB >> 3000928

Cytotoxic T lymphocytes and natural killer cell activity in the course of mengo virus infection of mice.

D Hassin, R Fixler, H Bank, A S Klein, Y Hasin.   

Abstract

Inbred C57BL/6 mice were inoculated intraperitoneally (i.p.) with mengo virus. The activity of cytotoxic T lymphocytes (CTL) and natural killer (NK) cells were measured during the first 22 days following infection. The CTL response began 7 days after virus inoculation, persisted for at least 22 days and was related to the dose of the virus inoculated. NK cell activity was elevated within 24 hr, reached its peak level on the fourth day and declined to normal levels on the eleventh day after exposure to the virus. These results suggest that NK cells represent the first cellular immune response to restrict mengo virus spread while specific CTL appear later and are probably responsible for further restriction, elimination and prevention of the viral disease.

Entities:  

Mesh:

Year:  1985        PMID: 3000928      PMCID: PMC1453805     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection.

Authors:  G V Quinnan; J E Manischewitz
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

2.  Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice.

Authors:  R M Welsh; R M Zinkernagel
Journal:  Nature       Date:  1977-08-18       Impact factor: 49.962

Review 3.  Genetic control of natural cytotoxicity and hybrid resistance.

Authors:  E A Clark; R C Harmon
Journal:  Adv Cancer Res       Date:  1980       Impact factor: 6.242

4.  Interferon in experimental viral infections in mice: tissue interferon levels resulting from the virus infection and from exogenous interferon therapy.

Authors:  H Heremans; A Billiau; P De Somer
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

5.  Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.

Authors:  C Y Wong; J J Woodruff; J F Woodruff
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

Review 6.  Major transplantation antigens, viruses, and specificity of surveillance T cells.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Contemp Top Immunobiol       Date:  1977

7.  Mechanisms for generating cell membrane antigens that are recognized by cytotoxic T lymphocytes.

Authors:  R Ciavarra; C Y Kang; J Forman
Journal:  Fed Proc       Date:  1981-02

8.  Monitoring the integrity of self: biology of MHC-restriction of virus-immune T cells.

Authors:  P C Doherty; J R Bennink
Journal:  Fed Proc       Date:  1981-02

9.  Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes.

Authors:  S A Huber; L P Job; J F Woodruff
Journal:  Am J Pathol       Date:  1980-03       Impact factor: 4.307

10.  Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction.

Authors:  R M Welsh
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  4 in total

1.  Protection against lethal encephalomyocarditis virus infection in the absence of serum-neutralizing antibodies.

Authors:  Z C Neal; G A Splitter
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

2.  Verapamil ameliorates the clinical and pathological course of murine myocarditis.

Authors:  R Dong; P Liu; L Wee; J Butany; M J Sole
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

3.  Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies.

Authors:  Z C Neal; G A Splitter
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

4.  Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef.

Authors:  Ziv Sevilya; Ehud Chorin; Orit Gal-Garber; Einat Zelinger; Dan Turner; Boaz Avidor; Gideon Berke; David Hassin
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.